Enteric-coated mycophenolate sodium in psoriasis vulgaris: An open pilot study

Journal of Dermatological Treatment

Volumn 25, Issue 1, 2014, Pages 46-49

  Fallah Arani, Shiva ^a,b   Waalboer Spuij, Rick ^a,b   Nijsten, Tamar ^a,b   Neumann, H A Martino ^a,b   Thio, Bing ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ALBERT SCHWEITZER HOSPITAL   (Netherlands)

Author keywords

Enteric coated mycophenolate sodium; Psoriasis; Therapy

Indexed keywords

MYCOPHENOLIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; DETERIORATION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENTERIC COATED TABLET; FEMALE; HEADACHE; HUMAN; MALE; PAIN; PILOT STUDY; PRIORITY JOURNAL; PRURITUS; PSORIASIS VULGARIS; SIDE EFFECT; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; DIARRHEA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PILOT PROJECTS; PRURITUS; PSORIASIS; TABLETS, ENTERIC-COATED; TREATMENT OUTCOME;

EID: 84890449778     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2012.723124     Document Type: Article

References (20)

1. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361: 496-509.
2. Lipsky JL. Mycophenolate mofetil. Lancet. 1996;348:1357-1359.
3. Davison SC, Morris-Jones R, Powles AV, Fry L. Change of treatment from cyclosporine to mycophenolate mofetil in severe psoriasis. Br J Dermatol. 2000;14:405-407.
4. Kreuter A, Tomi NS, Weiner SM, Huger M, Altmeyer P, Gambichler T. Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy. Br J Dermatol. 2007;15:1321-1327.
5. Geilen CC, Arnold M, Orfanos CE. Mycophenolate mofetil as a systemic antipsoriatic agent:positive experience in 11 patients. Br J Dermatol. 2001;144:583-586.
6. Budde K, Glander P, Diekmann F, Waiser J, Fritsche L, Dragun D, et al. Review of the immunosuppressant enteric-coated mycophenolate sodium. Expert Opin Pharmacother. 2004;5:1333-1345.
7. Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica. 1978;157:238-244.
8. Pedraz J, Daudén E, Delgado-Jiménez Y, García- Río I, García- Díez A. Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporine. J Eur Acad Dermatol Venereol. 2006;20:702-706.
9. Geilen CC, Tebbe B, García-Bartels C, Krengel S, Orfanos CE. Successful treatment of erythrodermic psoriasis with mycophenolate mofetil. Br J Dermatol. 1998;138:1101-1122.
10. Haufs MG, Beissert S, Grabbe S, Schutte B, Luger TA. Psoriasis vulgaris treated successfully with mycophenolate mofetil. Br J Dermatol. 1998; 138:179-181.
11. Tong DW, Walder BK. Widespread plaque psoriasis responsive to mycophenolate mofetil. Australas J Dermatol. 1999;40:135-137.
12. Nousari HC, Sragovich A, Kimyai-Asadi A, Orlinsky D, Anhalt GJ. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol. 1999;40:265-268.
13. Grundmann-Kollmann M, Mooser G, Schraeder P, Zollner T, Kaskel P, Ochsendorf F, et al. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil. J Am Acad Dermatol. 2000;42:835-837.
14. Dauden E, Sánchez-Peinado C, Ruiz-Genao D García-F-Villalta M, Onate MJ, García-Díez A. Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis. Br J Dermatol. 2004;150:132-135.
15. Sanford M, Keating GM. Enteric-coated mycophenolate sodium: a review of its use in the prevention of renal transplant rejection. Drugs. 2008;68:2505-2533.
16. Darji P, Vijayaraghavan R, Thiagarajan CM, Sharma RK, Subbarao B, Pishardy R, et al. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant recipients with gastrointestinal tract disorders. Transplant Proc. 2008;40: 2262-2267.
17. Zhou Y, Rosenthal D, Dutz J, Ho V. Mycophenolate mofetil (CellCept) for psoriasis: a two-center, prospective, open-label clinical trial. J Cutan Med Surg. 2003;7:193-197.
18. Orvis AK, Wesson SK, Breza TS Jr, Church AA, Mitchell CL, Watkins SW. Mycophenolate mofetil in dermatology. J Am Acad Dermatol. 2009;60:183-199.
19. Jackson JM, Fowler JF Jr, Callen JP, Lorenz DJ. Mycophenolate mofetil for the treatment of chronic dermatitis: an open-label study of 16 patients. J Drugs Dermatol. 2010;9:356-362.
20. van Velsen SG, Haeck IM, Bruijnzeel-Koomen CA, de Bruin- Weller MS. First experience with enteric-coated mycophenolate sodium (Myfortic(R)) in severe recalcitrant adult atopic dermatitis: an open label study. Br J Dermatol. 2009;160:687-691.